Q-FASTR Records

View as cards View as table112 Projects

	Fiscal Year Awarded	Principal Investigator
Non-invasive theranostics for endometriosis	2026	Ulrich von Andrian
Potassium channel enhancers to treat pain and epilepsy	2026	Bruce Bean
Potassium channel inhibitors for symptomatic treatment of multiple sclerosis	2026	Bruce Bean
Precision modulation of IL-10 pathways via IL-10 receptor-targeted nanobodies	2026	Jun Huh
Purification pipeline	2026	Michael Springer
Relaxin family peptide receptor 2 modulators as therapeutics	2026	Andrew Kruse
Targeted drug delivery across the blood-brain barrier	2026	Ulrich von Andrian
Targeting a protein to promote remyelination	2026	Lee Rubin
Targeting Ecdysone signaling for control of disease vector and other insects	2026	Norbert Perrimon
Targeting novel negative regulators to improve CAR T cell therapy responses in solid tumors	2026	Arlene Sharpe
Targeting tau hyperphosphorylation to develop novel therapeutics for Alzheimer’s Disease and other tauopathies	2026	John Flanagan
Therapeutic development of secreted peptides uncovered by Barcoded Ligand Sequencing	2026	Michael Greenberg
Towards the development of improved insect repellents	2026	Josefina del Marmol
V8 protease to treat S. aureus infection and atopic dermatitis	2026	Isaac Chiu
Developing a biomarker of homologous recombination deficiency for enhanced PARP inhibitor efficacy across cancers	2025	Peter Park
Developing a synthetic biology platform for pharmaceutical biomanufacturing	2025	Pamela Silver
Development of allosteric activators for immunotherapy	2025	Stephen Blacklow
Development of small molecule inhibitors of a gut bacterial metabolic toxin	2025	Sloan Devlin
In vivo gene editing to treat inherited Collagen VI-related myopathies	2025	Amy Wagers
In vivo strategy to induce tolerance to therapeutic proteins and autoantigens	2025	Amy Wagers

Q-FASTR Records

Filter Q-FASTR Records

Fiscal Year Awarded

Funding amount

Principal Investigator